Nivedita Gupta to Middle Aged
This is a "connection" page, showing publications Nivedita Gupta has written about Middle Aged.
Connection Strength
0.052
-
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):216-225.
Score: 0.014
-
Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):236-240.
Score: 0.014
-
An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses. 2021 05 17; 13(5).
Score: 0.004
-
SARS-CoV-2 re-infection: development of an epidemiological definition from India. Epidemiol Infect. 2021 03 26; 149:e82.
Score: 0.004
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961.
Score: 0.004
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
Score: 0.004
-
Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Health. 2019 08; 7(8):e1065-e1073.
Score: 0.003
-
Epidemiology of Hepatitis A and Hepatitis E Based on Laboratory Surveillance Data-India, 2014-2017. Am J Trop Med Hyg. 2018 10; 99(4):1058-1061.
Score: 0.003
-
First laboratory confirmation on the existence of Zika virus disease in India. J Infect. 2018 03; 76(3):314-317.
Score: 0.003